Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Shareholders' Equity

v3.20.2
Condensed Consolidated Statement of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Common Stock, Shares, Outstanding period beginning at Feb. 02, 2019   6,791,934    
Total Shareholders' Equity period beginning at Feb. 02, 2019 $ 64,951 $ 68 $ 442,808 $ (377,925)
Net income (loss) (20,990) $ 0 0 (20,990)
Common stock issuances pursuant to equity compensation awards, Shares   31,164    
Common stock issuances pursuant to equity compensation awards, Value (8) $ 0 (8) 0
Share-based payment compensation 966 $ 0 966 0
Common stock and warrant issuance, Shares   800,000    
Common stock and warrant issuance, Value 6,018 $ 8 6,010 0
Common Stock, Shares, Outstanding period end at May. 04, 2019   7,623,098    
Total Shareholders' Equity period end at May. 04, 2019 50,937 $ 76 449,776 (398,915)
Common Stock, Shares, Outstanding period beginning at Feb. 02, 2019   6,791,934    
Total Shareholders' Equity period beginning at Feb. 02, 2019 64,951 $ 68 442,808 (377,925)
Net income (loss) (37,908)      
Common Stock, Shares, Outstanding period end at Nov. 02, 2019   7,677,035.000    
Total Shareholders' Equity period end at Nov. 02, 2019 34,723 $ 77 450,479 (415,833)
Common Stock, Shares, Outstanding period beginning at May. 04, 2019   7,623,098    
Total Shareholders' Equity period beginning at May. 04, 2019 50,937 $ 76 449,776 (398,915)
Net income (loss) (10,177) $ 0 0 (10,177)
Common stock issuances pursuant to equity compensation awards, Shares   53,837    
Common stock issuances pursuant to equity compensation awards, Value (13) $ 1 (14) 0
Share-based payment compensation 291 $ 0 291 0
Common Stock, Shares, Outstanding period end at Aug. 03, 2019   7,676,935    
Total Shareholders' Equity period end at Aug. 03, 2019 41,038 $ 77 450,053 (409,092)
Net income (loss) (6,741) $ 0 0 (6,741)
Common stock issuances pursuant to equity compensation awards, Shares   100    
Common stock issuances pursuant to equity compensation awards, Value 0 $ 0 0 0
Share-based payment compensation 426 $ 0 426 0
Common Stock, Shares, Outstanding period end at Nov. 02, 2019   7,677,035.000    
Total Shareholders' Equity period end at Nov. 02, 2019 $ 34,723 $ 77 450,479 (415,833)
Common Stock, Shares, Outstanding period beginning at Feb. 01, 2020 8,208,227 8,208,227    
Total Shareholders' Equity period beginning at Feb. 01, 2020 $ 18,694 $ 82 452,833 (434,221)
Net income (loss) (6,828) $ 0 0 (6,828)
Common stock issuances pursuant to equity compensation awards, Shares   32,652    
Common stock issuances pursuant to equity compensation awards, Value (2) $ 1 (3) 0
Share-based payment compensation 615 $ 0 615 0
Common stock and warrant issuance, Shares   731,937    
Common stock and warrant issuance, Value 1,425 $ 7 1,418 0
Common Stock, Shares, Outstanding period end at May. 02, 2020   8,972,816    
Total Shareholders' Equity period end at May. 02, 2020 $ 13,904 $ 90 454,863 (441,049)
Common Stock, Shares, Outstanding period beginning at Feb. 01, 2020 8,208,227 8,208,227    
Total Shareholders' Equity period beginning at Feb. 01, 2020 $ 18,694 $ 82 452,833 (434,221)
Common stock and warrant issuance, Shares 1,836,314      
Common Stock, Shares, Outstanding period end at Aug. 01, 2020   10,141,649    
Total Shareholders' Equity period end at Aug. 01, 2020 $ 17,446 $ 101 457,340 (439,995)
Common Stock, Shares, Outstanding period beginning at Feb. 01, 2020 8,208,227 8,208,227    
Total Shareholders' Equity period beginning at Feb. 01, 2020 $ 18,694 $ 82 452,833 (434,221)
Net income (loss) $ (10,522)      
Common Stock, Shares, Outstanding period end at Oct. 31, 2020 13,016,660 13,016,660    
Total Shareholders' Equity period end at Oct. 31, 2020 $ 29,034 $ 130 473,647 (444,743)
Common Stock, Shares, Outstanding period beginning at May. 02, 2020   8,972,816    
Total Shareholders' Equity period beginning at May. 02, 2020 13,904 $ 90 454,863 (441,049)
Net income (loss) 1,054 $ 0 0 1,054
Common stock issuances pursuant to equity compensation awards, Shares   64,456    
Common stock issuances pursuant to equity compensation awards, Value (5) $ 1 (6) 0
Share-based payment compensation 108 $ 0 108 0
Common stock and warrant issuance, Shares   1,104,377    
Common stock and warrant issuance, Value 2,385 $ 10 2,375 0
Common Stock, Shares, Outstanding period end at Aug. 01, 2020   10,141,649    
Total Shareholders' Equity period end at Aug. 01, 2020 17,446 $ 101 457,340 (439,995)
Net income (loss) (4,748) $ 0 0 (4,748)
Common stock issuances pursuant to equity compensation awards, Shares   313    
Common stock issuances pursuant to equity compensation awards, Value $ (1) $ 0 (1) 0
Exercise of warrants, Shares 114,698 114,698    
Exercise of warrants, Value $ 0 $ 1 (1) 0
Share-based payment compensation 504 $ 0 504 0
Common stock and warrant issuance, Shares   2,760,000    
Common stock and warrant issuance, Value $ 15,833 $ 28 15,805 0
Common Stock, Shares, Outstanding period end at Oct. 31, 2020 13,016,660 13,016,660    
Total Shareholders' Equity period end at Oct. 31, 2020 $ 29,034 $ 130 $ 473,647 $ (444,743)